PERSPECTA

News from every angle

Back to headlines

Cheap Indian Generic Weight-Loss Drugs Expected After Patent Expiry

India's patent for semaglutide is set to expire on March 20, leading to expectations that approximately 50 branded generic weight-loss drugs will enter the market.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.